Experiment description of studies that identified FCRLA in exosomes

1 Experiment ID 76 ISEV standards ✔ EM EV Biophysical techniques ✔ TSG101|GAPDH|HSP90 EV Cytosolic markers ✔ CD81|CD9|CD63|LAMP1|MHCI EV Membrane markers ✔ HSP90B1 EV Negative markers ✘ EV Particle analysis Identified molecule protein Identification method Mass spectrometry PubMed ID 20224111     Organism Homo sapiens Experiment description Proteomics analysis of bladder cancer exosomes. Authors Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A. Journal name MCP Publication year 2010 Sample Bladder cancer cells Sample name HT1376 Isolation/purification methods Differential centrifugation Sucrose density gradient Flotation density 1.10-1.19 g/mL Molecules identified in the study Protein Methods used in the study Mass spectrometry [MALDI TOF/TOF] Western blotting FACS

Protein-protein interactions for FCRLA

Protein Interactor ExoCarta ID Identification method PubMed Species No interactions are found.

Pathways in which FCRLA is involved

No pathways found